Advanced Healthcare Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 11, 2025

Abstract Extracellular vesicles (EVs) have emerged as promising bioactive carriers for delivering therapeutic agents, including nucleic acids, proteins, and small‐molecule drugs, owing to their excellent physicochemical stability biocompatibility. However, comprehensive reviews on the various types of EV‐based nanomedicines cancer therapy remain scarce. This review explores potential EVs antitumor nanomedicines. Methods EV extraction, drug loading, engineering modifications are systematically examined, strengths limitations these technical approaches critically assessed. Additionally, key strategies developing therapies highlighted. Finally, opportunities challenges associated with advancing toward clinical translation discussed. With integration multiple disciplines, robust platforms expected be manufactured provide more personalized effective solutions oncology patients.

Language: Английский